Sort
30,917 grants matching “tumor microenvironment”
Mechanisms of Variant ER-alpha Function in Breast Cancer
$485,788Elaine T Alarid · University Of Wisconsin-Madison · R01 · FY2021 · CA
PD-1 blockade with cryoablation and dendritic vaccine to treat lymphoma
$485,760Yi Lin · Mayo Clinic Rochester · R01 · FY2022 · CA
Evaluation of Immune-based Combinations in Prostate Cancer
$485,739Ravi Madan · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Molecular imaging and system dynamics of tumor virotherapy
$485,734David J Dingli · Mayo Clinic Rochester · R01 · FY2015 · CA
Intracellular Trafficking and Signaling Of The B-cell Antigen Receptor
$485,710Susan Pierce · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Disease Progression Modeling of Bladder Cancer
$485,702Steve Goodison · Mayo Clinic Jacksonville · R01 · FY2023 · CA
Targeting cysteine import to induce ferroptotic cell death in pancreatic cancer
$485,683Kenneth P Olive · Columbia University Health Sciences · R01 · FY2024 · CA
Targeting Hypoxia-Induced Cancer-Cell Adaptation by Direct Inhibition of Akt and
$485,596Maurizio Pellecchia · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2011 · CA
Innate Immune Mechanisms Contributing to Cancer Growth in Obesity
$485,465Edgar G. Engleman · Stanford University · R01 · FY2022 · CA
Innate Immune Mechanisms Contributing to Cancer Growth in Obesity
$485,465Edgar G. Engleman · Stanford University · R01 · FY2023 · CA
Advancing immunotherapy through cross species studies of immune cell responses and immune checkpoint inhibitor effects in dogs and humans with invasive urinary bladder cancer
$485,357Deborah W Knapp · Purdue University · U01 · FY2024 · CA
Targeted therapeutics for ovarian cancer and its microenvironment - treatment and theoretical modeling
$485,191Gabriel Lopez-Berestein · University Of Tx Md Anderson Can Ctr · U01 · FY2019 · CA
Enhancing the efficacy of androgen signaling inhibitors in prostate cancer
$485,160Xiaoqi Liu · University Of Kentucky · R01 · FY2022 · CA
Enhancing the efficacy of androgen signaling inhibitors in prostate cancer
$485,160Xiaoqi Liu · University Of Kentucky · R01 · FY2023 · CA
Proj. 2: Combining immune checkpoint blockade with T cell activation
$485,132E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2021 · CA
ONC201/TIC10 Anti-tumor Effect Through Regulation of the TRAIL pathway
$485,090Wafik S El-Deiry · Brown University · R01 · FY2020 · CA
Developmental studies to inform clinical stratification and targeting of SHH MB
$484,999Alexandra L. Joyner · Sloan-Kettering Inst Can Research · R01 · FY2016 · CA
Mechanisms of PD-1 and Tim-3 crosstalk in tumor-infiltrating lymphocytes
$484,976Robert L Ferris · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · CA
Metabolic Control of Immune Suppression in Gliomas
$484,938Maciej S Lesniak · Northwestern University At Chicago · R01 · FY2017 · NS
Tumor heterogeneity and early outcome prediction: efficacy, timing of MRI and PET
$484,925Nina A. Mayr · University Of Washington · R01 · FY2014 · CA
NRG Oncology NCORP Research Base-BIQSFP
$484,899Deborah W Bruner · Nrg Oncology Foundation, Inc. · UG1 · FY2025 · CA
Investigating the Genesis of Tumor Immune Microenvironment (TIME) as a function of Inflammation
$484,830Mary Helen Barcellos-Hoff · University Of California, San Francisco · R01 · FY2024 · CA
Prostate Section
$484,825Peter Pinto · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Proton-coupled folate/antifolate transport
$484,821Israel David Goldman · Albert Einstein College Of Medicine, Inc · R01 · FY2016 · CA
Mechanisms of Variant ER-alpha Function in Breast Cancer
$484,754Elaine T Alarid · University Of Wisconsin-Madison · R01 · FY2023 · CA